Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

President Donald Trump

Trump Signs FDA User Fee Agreement into Law; PhRMA and BIO Applaud the Move

Washington, DC, August 21, 2017 — President Donald J. Trump on Friday signed into law a funding package for the Food and Drug Administration (FDA) that also takes steps to lower drug prices.

The FDA Reauthorization Act (FDARA) of 2017 reauthorizes a program in which drug and medical device makers pay the FDA a fee for every new product application.  The agency uses those funds to hire more people and speed up approvals.

The user fee program must be reauthorized every five years. The current program expires at the end of September, and if it hadn’t been signed into law before then, the agency would have had to lay off workers. Continue reading

Trump Administration Unveils First Blueprint for Federal Investment in Science and Tech; Departs from Its Budget Request

President Donald Trump

Washington, DC, August 21, 2017 — Jeffrey Mervis reports in Science that President Donald J. Trump on August 17 translated his campaign promise to “make America great again” into his administration’s first blueprint for federal investment in science and technology.

The White House on issued a four-page memo telling federal agencies that their research dollars should be focused on delivering short-term dividends in strengthening national defense and border security, the economy, and “energy dominance,” as well as improving public health. Continue reading

Kaiser Family Foundation Poll: 78 Percent Say Trump Should Try to Make Obamacare Work

Washington, DC, August 11, 2017 — Jessie Hellman reports in The Hill that 78 percent of Americans say President Trump and his administration should do what they can to make Obamacare work, according to a new Kaiser Family Foundation Poll released today.

That includes 95 percent of Democrats, 80 percent of independents and even a majority of Republicans at 52 percent, according to the.

Seventeen percent, though, think Trump should make the law fail so it can be replaced later. Continue reading

Trump Will Sign FDA User Fee Reauthorization Bill, Ending Threat of Agency Layoffs; Industry Praises Move

Washington, DC, August 8, 2017 — Zachary Brennan reported on Endpoints News that President Donald J. Trump will sign bipartisan legislation, passed by the U.S. Senate on August 3, that reauthorize the Food and Drug Administration (FDA) user fee programs for prescription drugs, generic drugs, medical devices and biosimilars for the next five years.

A spokesman for President Trump told Focus, “The President will sign this bill, but we look forward to working with Congress to address further negotiations.”

The Senate’s passage of the House bill by a vote of 94-1 — Bernie Sanders (D-VT) was the only vote against — came more than two years after negotiations on the reauthorization began. Continue reading

STAT: With Trump in White House, Obama Science Experts Operate Shadow Network to Press Their Positions in Washington

Washington, DC, August 7, 2017 — Lev Facher reports on STAT that nearly all of the Obama administration’s science staff has departed the White House since January, and the Trump administration has moved slowly to replace them.

In the meantime, however, an unofficial shadow office, stocked with Obama loyalists, is quietly at work.

The network, described to STAT by officials from the previous administration who are involved, is informal yet organized, allowing for a far-reaching if largely inconspicuous effort to continue advocating for the Obama science agenda. Continue reading

White House Opioid Commission Urges Trump: ‘Declare a National Emergency’ on Drug Overdoses; Chaired by Gov. Christie

Washington, DC, August 1, 2017 — Christopher Ingraham reports in The Washington Post that the President’s Commission on Combating Drug Addiction and the Opioid Crisis, chaired by Gov. Chris Christie, issued a preliminary report on Monday stating that its “first and most urgent recommendation” is for the president to “declare a national emergency under either the Public Health Service Act or the Stafford Act.”

“With approximately 142 Americans dying every day,” the report notes, “America is enduring a death toll equal to September 11th every three weeks.” Continue reading

Trump Administration Tapping Tech, Business CEOs and Academia for STEM Policy Approach

Washington, DC, July 31, 2017 — Margaret Talev reported on Bloomberg News reported that White House officials, including Ivanka Trump, have begun an outreach campaign to major technology, business and education leaders — including Laurene Powell Jobs and Apple’s Tim Cook — for advice on shaping funding approaches to science, technology, engineering and math education in U.S. public schools.

President Donald Trump’s daughter on July 26 joined Reed Cordish, the president’s special assistant for technology initiatives, on a conference call with politicians, educators and CEOs to discuss STEM education, according to two people with knowledge of the call. Continue reading

Report: States’ Federal Medicaid Funding Could Drop 39 Percent Over Two Decades Under GOP Plan

Washington, DC, July 17, 2017The Hill reports that federal Medicaid funding could drop by as much as 39 percent over the next two decades under Senate Republicans’ healthcare plan, according to a report presented at the National Governors Association meeting.

The report, authored by the consulting firm Avalere Health, estimates that the GOP’s plan to overhaul large parts of the country’s healthcare system would offer deep cuts to Medicaid, ranging from 27 to 39 percent.

Among the states that would be hit the hardest by the cuts are California, Washington, Oregon, Nevada, New Mexico, North Dakota, Minnesota and Kentucky, among others that would see funding reductions of 35 percent or more. Continue reading

AAAS CEO Rush Holt Urges U.S. Secretary of State to Name New Science & Technology Adviser

The Hon. Rush Holt

Washington, DC, July 15, 2017 — Secretary of State Rex W. Tillerson must act swiftly to appoint a respected scientist or engineer as his science and technology adviser upon the departure Vaughan Turekian, who has effectively presented the views of the global scientific community and helped incorporate scientific findings into foreign policy considerations, said Rush Holt, the CEO of the American Association for the Advancement of Science (AAAS), in a statement issued July 13.

“We urge Secretary Tillerson to ensure this progress continues by promptly naming a new science and technology adviser as well as to maintain the existing fellowship programs that bring young and established scientists and engineers to contribute to the important work at the State Department,” said Holt, who is a former New Jersey Congressman.   Continue reading

U.S. House Subcommittee Defies Trump’s Budget and Proposes $1.1 Billion Boost for NHI

Washington, DC, July 13, 2017 — Rachel Roubein reports in The Hill that the U.S. House of Representatives subcommittee controlling the purse strings of the National Institutes of Health (NIH) on July 12 proposed a $1.1 billion boost for the agency, defying the Trump administration’s push for cuts.

The White House had proposed slashing the nation’s medical research agency by $5.8 billion.

But it was clear from the get-go that Congress wouldn’t support cutting NIH’s budget, with members of both parties in opposition. Continue reading